BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18184868)

  • 1. Pathway analysis of primary central nervous system lymphoma.
    Tun HW; Personett D; Baskerville KA; Menke DM; Jaeckle KA; Kreinest P; Edenfield B; Zubair AC; O'Neill BP; Lai WR; Park PJ; McKinney M
    Blood; 2008 Mar; 111(6):3200-10. PubMed ID: 18184868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression.
    Yuan J; Gu K; He J; Sharma S
    Hum Pathol; 2013 Apr; 44(4):606-11. PubMed ID: 23089492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray Gene-expression Profiling Analysis Comparing PCNSL and Non-CNS Diffuse Large B-Cell Lymphoma.
    Lim DH; Kim WS; Kim SJ; Yoo HY; Ko YH
    Anticancer Res; 2015 Jun; 35(6):3333-40. PubMed ID: 26026093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
    Fischer L; Hummel M; Korfel A; Lenze D; Joehrens K; Thiel E
    Neuro Oncol; 2011 Oct; 13(10):1090-8. PubMed ID: 21803762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.
    Vogt J; Wagener R; Montesinos-Rongen M; Ammerpohl O; Paulus W; Deckert M; Siebert R
    Genes Chromosomes Cancer; 2019 Jan; 58(1):66-69. PubMed ID: 30284345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.
    Akhter A; Masir N; Elyamany G; Phang KC; Mahe E; Al-Zahrani AM; Shabani-Rad MT; Stewart DA; Mansoor A
    J Neurooncol; 2015 Jan; 121(2):289-96. PubMed ID: 25391967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
    Lemma SA; Pasanen AK; Haapasaari KM; Sippola A; Sormunen R; Soini Y; Jantunen E; Koivunen P; Salokorpi N; Bloigu R; Turpeenniemi-Hujanen T; Kuittinen O
    Eur J Haematol; 2016 May; 96(5):492-501. PubMed ID: 26153511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice.
    Deckert M; Montesinos-Rongen M; Brunn A; Siebert R
    Acta Neuropathol; 2014 Feb; 127(2):175-88. PubMed ID: 24240734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
    Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S
    Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Tim-1 in primary CNS lymphoma.
    Kishimoto W; Nishikori M; Arima H; Miyoshi H; Sasaki Y; Kitawaki T; Shirakawa K; Kato T; Imaizumi Y; Ishikawa T; Ohno H; Haga H; Ohshima K; Takaori-Kondo A
    Cancer Med; 2016 Nov; 5(11):3235-3245. PubMed ID: 27709813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.
    Lemma SA; Kuusisto M; Haapasaari KM; Sormunen R; Lehtinen T; Klaavuniemi T; Eray M; Jantunen E; Soini Y; Vasala K; Böhm J; Salokorpi N; Koivunen P; Karihtala P; Vuoristo J; Turpeenniemi-Hujanen T; Kuittinen O
    Carcinogenesis; 2017 Aug; 38(8):812-820. PubMed ID: 28854563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
    Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
    Booman M; Szuhai K; Rosenwald A; Hartmann E; Kluin-Nelemans H; de Jong D; Schuuring E; Kluin P
    J Pathol; 2008 Oct; 216(2):209-17. PubMed ID: 18729069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study.
    Labreche K; Daniau M; Sud A; Law PJ; Royer-Perron L; Holroyd A; Broderick P; Went M; Benazra M; Ahle G; Soubeyran P; Taillandier L; Chinot OL; Casasnovas O; Bay JO; Jardin F; Oberic L; Fabbro M; Damaj G; Brion A; Mokhtari K; Philippe C; Sanson M; Houillier C; Soussain C; Hoang-Xuan K; Houlston RS; Alentorn A;
    Neuro Oncol; 2019 Aug; 21(8):1039-1048. PubMed ID: 31102405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.
    Braggio E; Van Wier S; Ojha J; McPhail E; Asmann YW; Egan J; da Silva JA; Schiff D; Lopes MB; Decker PA; Valdez R; Tibes R; Eckloff B; Witzig TE; Stewart AK; Fonseca R; O'Neill BP
    Clin Cancer Res; 2015 Sep; 21(17):3986-94. PubMed ID: 25991819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
    Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Array-based DNA methylation profiling of primary lymphomas of the central nervous system.
    Richter J; Ammerpohl O; Martín-Subero JI; Montesinos-Rongen M; Bibikova M; Wickham-Garcia E; Wiestler OD; Deckert M; Siebert R
    BMC Cancer; 2009 Dec; 9():455. PubMed ID: 20025734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of chemokines, chemokine receptors, cytokines and cytokine receptors in diffuse large B cell malignant lymphoma.
    Fujii A; Ohshima K; Hamasaki M; Makimoto Y; Haraoka S; Utsunomiya H; Okazaki M; Kikuchi M
    Int J Oncol; 2004 Mar; 24(3):529-38. PubMed ID: 14767537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genomic and transcriptional landscape of primary central nervous system lymphoma.
    Radke J; Ishaque N; Koll R; Gu Z; Schumann E; Sieverling L; Uhrig S; Hübschmann D; Toprak UH; López C; Hostench XP; Borgoni S; Juraeva D; Pritsch F; Paramasivam N; Balasubramanian GP; Schlesner M; Sahay S; Weniger M; Pehl D; Radbruch H; Osterloh A; Korfel A; Misch M; Onken J; Faust K; Vajkoczy P; Moskopp D; Wang Y; Jödicke A; Trümper L; Anagnostopoulos I; Lenze D; Küppers R; Hummel M; Schmitt CA; Wiestler OD; Wolf S; Unterberg A; Eils R; Herold-Mende C; Brors B; ; Siebert R; Wiemann S; Heppner FL
    Nat Commun; 2022 May; 13(1):2558. PubMed ID: 35538064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.